A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

Active, not recruitingOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

February 22, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2027

Conditions
COVID-19
Interventions
OTHER

Follow-up

Follow-up of neurocognitive and psychiatric symptoms in Post COVID patients (baseline, 12 months, 24 months) in correlation with biomarkers using MRI, fMRI, neuropsychological testing, lab samples (blood, CSF, microbiota).

Trial Locations (1)

Unknown

Department of Geriatrics, University Hospital Örebro, Örebro

All Listed Sponsors
collaborator

Örebro University, Sweden

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

Karolinska University Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

lead

Region Örebro County

OTHER